Skip to content

SOP 22.042

PERSONAL PROTECTIVE EQUIPMENT (PPE) TO BE WORN WHEN HANDLING GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.041

ASEPTIC PREPARATION OF GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.040

SAFE HANDLING OF SPILLAGE, PERSONAL CONTAMINATION OR INJURY INVOLVING GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.039

CLEANING THE ASEPTIC ROOM AND ISOLATOR USED TO PREPARE GENETICALLY MODIFIED ORGANISM PRODUCTS (GMO)   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.038

INTRODUCTION TO GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS WITHIN CLINICAL TRIALS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.037

Tracking and Release of IMPs placed into quarantine post delivery at pharmacy sites   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.035

Clinical Trial Information Provided to Site On-Call Pharmacists   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.034

Management of controlled drug IMPs within pharmacy sites   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.033

Incident reporting for pharmacy clinical trials   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.031

Role of pharmacy services in support of trials that are hosted by NHS GG&C: an overview   For Password contact Lead Pharmacist Clinical Trials R&I